MicroRNAs and Chinese Medicinal Herbs: New Possibilities in Cancer Therapy

In recent decades Chinese medicine has been used worldwide as a complementary and alternative medicine to treat cancer. Plenty of studies have shown that microRNAs (miRNAs) play fundamental roles in many pathological processes, including cancer, while the anti-cancer mechanisms of Chinese medicinal herbs targeting miRNAs also have been extensively explored. Our previous studies and those of others on Chinese medicinal herbs and miRNAs in various cancer models have provided a possibility of new cancer therapies, for example, up-regulating the expression of miR-23a may activate the positive regulatory network of p53 and miR-23a involved in the mechanism underlying the anti-tumor effect of berberine in hepatocellular carcinoma (HCC). In this review, we survey the role of Chinese medicinal herbal products in regulating miRNAs in cancer and the use of mediating miRNAs for cancer treatment. In addition, the controversial roles of herb-derived exogenous miRNAs in cancer treatment are also discussed. It is expected that targeting miRNAs would provide a novel therapeutic approach in cancer therapy by improving overall response and survival outcomes in cancer treatment, especially when combined with conventional therapeutics and Chinese medicinal herbal products.

[1]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[2]  Qingsong Wang,et al.  Quantitative Nuclear Proteomics Identifies that miR-137-mediated EZH2 Reduction Regulates Resveratrol-induced Apoptosis of Neuroblastoma Cells* , 2014, Molecular & Cellular Proteomics.

[3]  Y. Shu,et al.  Luteolin Induces Apoptosis by Up-regulating miR-34a in Human Gastric Cancer Cells , 2015, Technology in cancer research & treatment.

[4]  L. Pfeffer,et al.  The Curcumin Analog EF24 Targets NF-κB and miRNA-21, and Has Potent Anticancer Activity In Vitro and In Vivo , 2013, PloS one.

[5]  G. Capranico,et al.  The Natural Inhibitor of DNA Topoisomerase I, Camptothecin, Modulates HIF-1α Activity by Changing miR Expression Patterns in Human Cancer Cells , 2013, Molecular Cancer Therapeutics.

[6]  Hugo Naya,et al.  Mining of public sequencing databases supports a non-dietary origin for putative foreign miRNAs: underestimated effects of contamination in NGS , 2014, RNA.

[7]  K. Zen,et al.  Reply to Lack of detectable oral bioavailability of plant microRNAs after feeding in mice , 2013, Nature Biotechnology.

[8]  Yau-Huei Wei,et al.  Resveratrol Impedes the Stemness, Epithelial-Mesenchymal Transition, and Metabolic Reprogramming of Cancer Stem Cells in Nasopharyngeal Carcinoma through p53 Activation , 2013, Evidence-based complementary and alternative medicine : eCAM.

[9]  C. Ling,et al.  Application of traditional Chinese medicine injection in treatment of primary liver cancer: a review. , 2012, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

[10]  Jin-hai Tang,et al.  A clinical study on safety and efficacy of Aidi injection combined with chemotherapy. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[11]  Hui Zhang,et al.  Aidi injection alters the expression profiles of microRNAs in human breast cancer cells. , 2011, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

[12]  H. Feng,et al.  Ginsenoside Rh2 inhibits glioma cell proliferation by targeting microRNA-128 , 2011, Acta Pharmacologica Sinica.

[13]  X. Chen,et al.  Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA , 2011, Cell Research.

[14]  Dan Yang,et al.  [Review of experimental study on treatment of lung cancer with traditional Chinese medicine]. , 2009, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[15]  Young Kee Shin,et al.  Molecular function and regulation of long non-coding RNAs: paradigms with potential roles in cancer , 2014, Tumor Biology.

[16]  Masaharu Kataoka,et al.  Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease , 2014, Cells.

[17]  E. Kroh,et al.  Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma , 2011, Proceedings of the National Academy of Sciences.

[18]  S. Tsao,et al.  Berberine-induced tumor suppressor p53 up-regulation gets involved in the regulatory network of MIR-23a in hepatocellular carcinoma. , 2014, Biochimica et biophysica acta.

[19]  R. Dahiya,et al.  Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells , 2014, British Journal of Cancer.

[20]  A. Abdel‐Mageed,et al.  MicroRNA expression profiles in differentiated thyroid cancer, a review. , 2013, International journal of clinical and experimental medicine.

[21]  R. Pieters,et al.  MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia. , 2013, Leukemia research.

[22]  I. Irminger-Finger,et al.  Non-coding RNAs: a novel level of genome complexity. , 2014, The international journal of biochemistry & cell biology.

[23]  Junhua Wu,et al.  Integrated microRNA-mRNA analysis revealing the potential roles of microRNAs in tongue squamous cell cancer , 2015, Molecular medicine reports.

[24]  Shun-Fa Yang,et al.  Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas , 2014, Oncotarget.

[25]  V. Macrae,et al.  miRNA-221 and miRNA-222 synergistically function to promote vascular calcification , 2013, Cell biochemistry and function.

[26]  Wei Chen,et al.  Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis. , 2010, American journal of translational research.

[27]  P. Lei,et al.  Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression , 2013, Clinical and Translational Oncology.

[28]  S. Yuan,et al.  Down‐regulation of some miRNAs by degrading their precursors contributes to anti‐cancer effect of mistletoe lectin‐I , 2011, British journal of pharmacology.

[29]  Qinbo Yang,et al.  Bidirectional regulation of angiogenesis and miR-18a expression by PNS in the mouse model of tumor complicated by myocardial ischemia , 2014, BMC Complementary and Alternative Medicine.

[30]  Min Pan,et al.  A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers , 2012, Genome research.

[31]  Mario Boccadoro,et al.  Biological and Clinical Relevance of miRNA Expression Signatures in Primary Plasma Cell Leukemia , 2013, Clinical Cancer Research.

[32]  Y. Jeon,et al.  Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization , 2013, BMC Cancer.

[33]  F. Sarkar,et al.  Difluorinated-Curcumin (CDF) Restores PTEN Expression in Colon Cancer Cells by Down-Regulating miR-21 , 2013, PloS one.

[34]  J. McNamara.  Cancer Stem Cells , 2007, Methods in Molecular Biology.

[35]  H. Sorbye,et al.  Let-7 miRNA-binding site polymorphism in the KRAS 3′UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab , 2012, BMC Cancer.

[36]  Y. Pekarsky,et al.  Reprogramming of miRNA networks in cancer and leukemia. , 2010, Genome research.

[37]  D. Ma,et al.  Honokiol Suppresses Renal Cancer Cells’ Metastasis via Dual-Blocking Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties through Modulating miR-141/ZEB2 Signaling , 2014, Molecules and cells.

[38]  W. Du,et al.  Matrine Inhibits Breast Cancer Growth Via miR-21/PTEN/Akt Pathway in MCF-7 Cells , 2012, Cellular Physiology and Biochemistry.

[39]  Li-Zhu Lin,et al.  Standardized treatment of chinese medicine decoction for cancer pain patients with opioid-induced constipation: A multi-center prospective randomized controlled study , 2014, Chinese Journal of Integrative Medicine.

[40]  K. Witwer,et al.  Real-time quantitative PCR and droplet digital PCR for plant miRNAs in mammalian blood provide little evidence for general uptake of dietary miRNAs Limited evidence for general uptake of dietary plant xenomiRs , 2013 .

[41]  Shiguo Liu,et al.  Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis. , 2013, Acta biochimica et biophysica Sinica.

[42]  W. Lukiw.  Variability in micro RNA (miRNA) abundance, speciation and complexity amongst different human populations and potential relevance to Alzheimer's disease (AD) , 2013, Front. Cell. Neurosci..

[43]  M. Hung,et al.  MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol , 2013, Oncogene.

[44]  C. Peng,et al.  MicroRNA-33b, upregulated by EF24, a curcumin analog, suppresses the epithelial-to-mesenchymal transition (EMT) and migratory potential of melanoma cells by targeting HMGA2. , 2015, Toxicology letters.

[45]  K. Dou,et al.  Differentiation-Inducing Activity of Hydroxycamptothecin on Cancer Stem-Like Cells Derived from Hepatocellular Carcinoma , 2011, Digestive Diseases and Sciences.

[46]  S. Rushworth.  Targeting the oncogenic role of miRNA in human cancer using naturally occurring compounds , 2011, British journal of pharmacology.

[47]  Jian-Ping Liu,et al.  Chinese herbal medicine for cancer-related fatigue: a systematic review of randomized clinical trials. , 2014, Complementary therapies in medicine.

[48]  R. Wong,et al.  Role of microRNA-214 in ginsenoside-Rg1-induced angiogenesis. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[49]  Zhiwei Wang,et al.  miR-146a suppresses invasion of pancreatic cancer cells. , 2010, Cancer research.

[50]  Hsien-Da Huang,et al.  A systematic review of microRNA expression profiling studies in human gastric cancer , 2014, Cancer medicine.

[51]  H. Nojima,et al.  Gefitinib and Luteolin Cause Growth Arrest of Human Prostate Cancer PC-3 Cells via Inhibition of Cyclin G-Associated Kinase and Induction of miR-630 , 2014, PloS one.

[52]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[53]  Yuanji Zhang,et al.  Lack of detectable oral bioavailability of plant microRNAs after feeding in mice , 2013, Nature Biotechnology.

[54]  Jian-yong Li,et al.  [Detection of miRNA levels in leukemia patients by real-time quantitative PCR]. , 2010, Zhongguo shi yan xue ye xue za zhi.

[55]  R. Pocock.  Invited review: decoding the microRNA response to hypoxia , 2011, Pflügers Archiv - European Journal of Physiology.

[56]  Yan Lin,et al.  Combination of Matrine and Sorafenib Decreases the Aggressive Phenotypes of Hepatocellular Carcinoma Cells , 2015, Chemotherapy.

[57]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[58]  Xiaochuang Luo,et al.  Systematic analysis of berberine-induced signaling pathway between miRNA clusters and mRNAs and identification of mir-99a∼125b cluster function by seed-targeting inhibitors in multiple myeloma cells , 2015, RNA biology.

[59]  Evelyn Wenkel,et al.  Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection , 2012, PloS one.

[60]  D. Chan,et al.  Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer , 2013, Oncotarget.

[61]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[62]  Jie Yuan,et al.  MicroRNA in Human Glioma , 2013, Cancers.

[63]  H. Liu,et al.  Breakthrough cancer medicine and its impact on novel drug development in China: report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting , 2014, Chinese journal of cancer.

[64]  Yue-Qin Chen,et al.  Camptothecin Induces Apoptosis in Cancer Cells via MicroRNA-125b-Mediated Mitochondrial Pathways , 2012, Molecular Pharmacology.

[65]  D. Wodarz,et al.  Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer. , 2015, Carcinogenesis.

[66]  Xiang Zhou,et al.  A review: microRNA detection methods. , 2015, Organic & biomolecular chemistry.

[67]  T. Brabletz.  EMT and MET in metastasis: where are the cancer stem cells? , 2012, Cancer cell.

[68]  M. Yuen,et al.  Up-regulation of microRNAs, miR21 and miR23a in human liver cancer cells treated with Coptidis rhizoma aqueous extract. , 2011, Experimental and therapeutic medicine.

[69]  W. Chen,et al.  Ginsenoside Rh2 Targets EGFR by Up-Regulation of miR-491 to Enhance Anti-tumor Activity in Hepatitis B Virus-Related Hepatocellular Carcinoma , 2015, Cell Biochemistry and Biophysics.

[70]  T. Ghosh,et al.  Insights into the miRNA regulations in human disease genes , 2014, BMC Genomics.